We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.5M
AUM Growth
+$3.46M
Cap. Flow
+$4.95M
Cap. Flow %
5.73%
Top 10 Hldgs %
90.67%
Holding
43
New
11
Increased
–
Reduced
8
Closed
11

Top Buys

Rank Stock Value
1
NGEN
NervGen Pharma
NGEN
+$12.4M
2
CLNN icon
Clene
CLNN
+$5.71M
3
ANVS icon
Annovis Bio
ANVS
+$4.67M
4
YDDL
One and One Green Technologies
YDDL
+$3.59M
5
AMC icon
AMC Entertainment Holdings
AMC
+$2.95M

Top Sells

Rank Stock Value
1
DTIL icon
Precision BioSciences
DTIL
+$8.39M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$8.26M
3
IMPP icon
Imperial Petroleum
IMPP
+$3.76M
4
VENU
Venu Holding Corp
VENU
+$1.77M
5
BSIN
Big Sky Industrial
BSIN
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 69.15%
2 Consumer Discretionary 12.06%
3 Consumer Staples 6.52%
4 Communication Services 5.11%
5 Materials 1.92%

No holdings matched the selected filter criteria.

1 2

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Empery Asset Management held 43 positions worth $86.5M, up 4.2% from $83M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Empery Asset Management deployed $4.95M of net new capital in Q2 2026, opening 11 new positions. Its largest new stake was NervGen Pharma: 4,000,000 shares worth $8.24M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 67% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Precision BioSciences, an estimated $8.39M trimmed.

  • Empery Asset Management's largest Q2 2026 buy was NervGen Pharma: 4,000,000 shares worth $8.24M.
  • Empery Asset Management's biggest Q2 2026 reduction was Precision BioSciences, cutting an estimated $8.39M.
  • Empery Asset Management fully exited Imperial Petroleum in Q2 2026, selling an estimated $3.76M.
  • Empery Asset Management's ten largest holdings make up 91% of its $86.5M portfolio in Q2 2026.
  • Empery Asset Management opened 11 new positions and closed 11 in Q2 2026.
  • Empery Asset Management's portfolio value rose 4.2% quarter-over-quarter to $86.5M.

Based on Empery Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.